531 related articles for article (PubMed ID: 18728607)
1. Comparison of N-butyl cyanoacrylate and onyx for the embolization of intracranial arteriovenous malformations: analysis of fluoroscopy and procedure times.
Velat GJ; Reavey-Cantwell JF; Sistrom C; Smullen D; Fautheree GL; Whiting J; Lewis SB; Mericle RA; Firment CS; Hoh BL
Neurosurgery; 2008 Jul; 63(1 Suppl 1):ONS73-8; discussion ONS78-80. PubMed ID: 18728607
[TBL] [Abstract][Full Text] [Related]
2. Multimodality treatment of brain arteriovenous malformations with microsurgery after embolization with onyx: single-center experience and technical nuances.
Natarajan SK; Ghodke B; Britz GW; Born DE; Sekhar LN
Neurosurgery; 2008 Jun; 62(6):1213-25; discussion 1225-6. PubMed ID: 18824988
[TBL] [Abstract][Full Text] [Related]
3. Complication risk of endovascular embolization for cerebral arteriovenous malformation.
Lv X; Wu Z; Jiang C; Li Y; Yang X; Zhang Y; Zhang N
Eur J Radiol; 2011 Dec; 80(3):776-9. PubMed ID: 20950972
[TBL] [Abstract][Full Text] [Related]
4. A prospective, multicenter, randomized trial of the Onyx liquid embolic system and N-butyl cyanoacrylate embolization of cerebral arteriovenous malformations. Clinical article.
Loh Y; Duckwiler GR;
J Neurosurg; 2010 Oct; 113(4):733-41. PubMed ID: 20433277
[TBL] [Abstract][Full Text] [Related]
5. Neurological morbidity and mortality associated with the endovascular treatment of cerebral arteriovenous malformations before and during the Onyx era.
Crowley RW; Ducruet AF; Kalani MY; Kim LJ; Albuquerque FC; McDougall CG
J Neurosurg; 2015 Jun; 122(6):1492-7. PubMed ID: 25816081
[TBL] [Abstract][Full Text] [Related]
6. Combined therapy of cerebral arteriovenous malformations: histological differences between a non-adhesive liquid embolic agent and n-butyl 2-cyanoacrylate (NBCA).
Duffner F; Ritz R; Bornemann A; Freudenstein D; Wiendl H; Siekmann R
Clin Neuropathol; 2002; 21(1):13-7. PubMed ID: 11846039
[TBL] [Abstract][Full Text] [Related]
7. Stereotactic radiosurgery for arteriovenous malformations after Onyx embolization: a case-control study.
Lee CC; Chen CJ; Ball B; Schlesinger D; Xu Z; Yen CP; Sheehan J
J Neurosurg; 2015 Jul; 123(1):126-35. PubMed ID: 25658780
[TBL] [Abstract][Full Text] [Related]
8. Letter: Comparison of N-butyl Cyanoacrylate and Onyx for the Embolization of Intracranial Arteriovenous Malformations-Analysis of Fluoroscopy and Procedure Times.
Lv X
Oper Neurosurg (Hagerstown); 2017 Dec; 13(6):E37-E38. PubMed ID: 29087510
[No Abstract] [Full Text] [Related]
9. Histopathological changes in brain arteriovenous malformations after embolization using Onyx or N-butyl cyanoacrylate. Laboratory investigation.
Natarajan SK; Born D; Ghodke B; Britz GW; Sekhar LN
J Neurosurg; 2009 Jul; 111(1):105-13. PubMed ID: 19326974
[TBL] [Abstract][Full Text] [Related]
10. Onyx embolization as a first line treatment for intracranial dural arteriovenous fistulas with cortical venous reflux.
Panagiotopoulos V; Möller-Hartmann W; Asgari S; Sandalcioglu IE; Forsting M; Wanke I
Rofo; 2009 Feb; 181(2):129-38. PubMed ID: 19101880
[TBL] [Abstract][Full Text] [Related]
11. Neurological outcomes and cure rates of embolization of brain arteriovenous malformations with n-butyl cyanoacrylate or Onyx: a meta-analysis.
Elsenousi A; Aletich VA; Alaraj A
J Neurointerv Surg; 2016 Mar; 8(3):265-72. PubMed ID: 25540177
[TBL] [Abstract][Full Text] [Related]
12. Complications of cerebral arteriovenous malformation embolization: multivariate analysis of predictive factors.
Ledezma CJ; Hoh BL; Carter BS; Pryor JC; Putman CM; Ogilvy CS
Neurosurgery; 2006 Apr; 58(4):602-11; discussion 602-11. PubMed ID: 16575323
[TBL] [Abstract][Full Text] [Related]
13. Hemorrhage risk after partial endovascular NBCA and ONYX embolization for brain arteriovenous malformation.
Lv X; Wu Z; Li Y; Yang X; Jiang C
Neurol Res; 2012 Jul; 34(6):552-6. PubMed ID: 22663933
[TBL] [Abstract][Full Text] [Related]
14. [Clinical experience of 70 cases of cerebral arteriovenous malformations embolization with Onyx, a novel liquid embolic agent].
Song DL; Leng B; Xu B; Wang QH; Chen XC; Zhou LF
Zhonghua Wai Ke Za Zhi; 2007 Feb; 45(4):223-5. PubMed ID: 17502012
[TBL] [Abstract][Full Text] [Related]
15. Preoperative embolization of intracranial arteriovenous malformations with Onyx.
Weber W; Kis B; Siekmann R; Jans P; Laumer R; Kühne D
Neurosurgery; 2007 Aug; 61(2):244-52; discussion 252-4. PubMed ID: 17762736
[TBL] [Abstract][Full Text] [Related]
16. Use of the Apollo detachable-tip microcatheter for endovascular embolization of arteriovenous malformations and arteriovenous fistulas.
Flores BC; See AP; Weiner GM; Jankowitz BT; Ducruet AF; Albuquerque FC
J Neurosurg; 2018 Mar; 130(3):963-971. PubMed ID: 29570006
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic effect of embolization of brain arteriovenous malformation with non-adhesive liquid embolic agent].
Li XS; Qi TW; Guo SL; Shi ZS; Huang ZS; Liang F; Jiang XB
Nan Fang Yi Ke Da Xue Xue Bao; 2008 Dec; 28(12):2192-5. PubMed ID: 19114354
[TBL] [Abstract][Full Text] [Related]
18. Endovascular treatment of intracranial arterio-venous malformations with Onyx embolization: preliminary experience.
Florio F; Lauriola W; Nardella M; Strizzi V; Vallone S; Trossello MP
Radiol Med; 2003; 106(5-6):512-20. PubMed ID: 14735018
[TBL] [Abstract][Full Text] [Related]
19. Onyx embolization of intracranial arteriovenous malformations in pediatric patients.
Soltanolkotabi M; Schoeneman SE; Alden TD; Hurley MC; Ansari SA; DiPatri AJ; Tomita T; Shaibani A
J Neurosurg Pediatr; 2013 Apr; 11(4):431-7. PubMed ID: 23394354
[TBL] [Abstract][Full Text] [Related]
20. ONYX versus n-BCA for embolization of cranial dural arteriovenous fistulas.
Rabinov JD; Yoo AJ; Ogilvy CS; Carter BS; Hirsch JA
J Neurointerv Surg; 2013 Jul; 5(4):306-10. PubMed ID: 22550096
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
